PubRank

M C Rogge

Author PubWeight™ 19.45‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Pharmacokinetic profile of levofloxacin following once-daily 500-milligram oral or intravenous doses. Antimicrob Agents Chemother 1997 2.44
2 Self-emulsifying drug delivery systems: formulation and biopharmaceutic evaluation of an investigational lipophilic compound. Pharm Res 1992 2.03
3 Activity of levofloxacin in a murine model of tuberculosis. Antimicrob Agents Chemother 1994 1.79
4 Pharmacokinetic profiles of ciprofloxacin after single intravenous and oral doses. Antimicrob Agents Chemother 1992 1.59
5 Absence of age and gender effects on the pharmacokinetics of a single 500-milligram oral dose of levofloxacin in healthy subjects. Antimicrob Agents Chemother 1997 1.50
6 Bioequivalence of oral and intravenous ofloxacin after multiple-dose administration to healthy male volunteers. Antimicrob Agents Chemother 1993 1.22
7 In vitro and in vivo activities of WIN 54954, a new broad-spectrum antipicornavirus drug. Antimicrob Agents Chemother 1989 1.22
8 Absence of a pharmacokinetic interaction between digoxin and levofloxacin. J Clin Pharm Ther 2002 1.05
9 Pharmacokinetics and safety of oral levofloxacin in human immunodeficiency virus-infected individuals receiving concomitant zidovudine. Antimicrob Agents Chemother 1997 0.91
10 Pharmacokinetics/dynamics of 5c8, a monoclonal antibody to CD154 (CD40 ligand) suppression of an immune response in monkeys. J Pharmacol Exp Ther 1998 0.89
11 Vancomycin disposition during continuous ambulatory peritoneal dialysis: a pharmacokinetic analysis of peritoneal drug transport. Antimicrob Agents Chemother 1985 0.86
12 Effect of food and a monoglyceride emulsion formulation on danazol bioavailability. J Clin Pharmacol 1993 0.83
13 Integration of pharmacokinetic and pharmacodynamic studies in the discovery, development, and review of protein therapeutic agents: a conference report. Clin Pharmacol Ther 2001 0.82
14 Absorption of danazol after administration to different sites of the gastrointestinal tract and the relationship to single- and double-peak phenomena in the plasma profiles. J Clin Pharmacol 1993 0.79
15 Bioavailability of hydrochlorothiazide from tablets and suspensions. J Pharm Sci 1984 0.78
16 Pharmacokinetics and distribution in tissue of FK-037, a new parenteral cephalosporin. Antimicrob Agents Chemother 1994 0.75
17 Absorption of theophylline from two sustained release formulations. Biopharm Drug Dispos 1985 0.75
18 A pharmacokinetic comparison of cephalexin and cefadroxil using HPLC assay procedures. Biopharm Drug Dispos 1985 0.75
19 Single dose and steady-state pharmacokinetics of adinazolam after oral administration to man. Biopharm Drug Dispos 1987 0.75
20 Enbrel (etanercept). Dev Biol (Basel) 2002 0.75
21 Bioavailability and relative tissue distribution of [125I]-recombinant human thrombin following intravenous or subcutaneous administration to non-human primates. J Thromb Haemost 2006 0.75
22 Comparative pharmacokinetics and pharmacodynamics of recombinant human interferon beta-1a after intramuscular and subcutaneous administration. Eur J Neurol 1999 0.75
23 Bioavailability of hydrocortisone from commercial 20-mg tablets. J Pharm Sci 1984 0.75
24 Probing a Kondo-correlated quantum dot with spin spectroscopy. Phys Rev Lett 2006 0.75